No Data
No Data
RemeGen Co., Ltd. (HKG:9995) Shares Fly 32% But Investors Aren't Buying For Growth
Have RemeGen Insiders Been Selling Stock?
Biomedical sector showing strong performance, Pharmaron (03759) rose by 14.97%. Institutions believe there is still room for further increase in sector valuation.
Golden Finance News | The biomedical sector is showing strong performance, with Pharmaron (03759) up 14.97%, Remegen (09995) up 13.59%, Tigermed (03347) up 12.58%, Wuxi Bio (02269) up 11.79%, Wuxi Apptec (02359) up 10.56%, Akeso (09926) up 8.92%. In terms of news, Guoyuan International believes that the main reason for the outperformance of the pharmaceutical sector in this round of large gains is due to the deeper decline in the pharmaceutical sector in the previous period (as of September 23, MSCI China Meheco Group Index has fallen 23% year-to-date), sector.
Recent Uptick Might Appease RemeGen Co., Ltd. (HKG:9995) Institutional Owners After Losing 67% Over the Past Year
REMEGEN: 2024 Interim Report
Market Chatter: RemeGen Denies Rumors of Mass Layoffs; Shares Up 4%
No Data
No Data